Why Flu Season Hits Hard, and How Labs Can Prepare

Each year, seasonal influenza resurfaces in force, bringing waves of illness that strain public health systems and laboratories alike. In the United States, flu season usually begins in the fall and peaks during the winter months – most often between December and February. (Over a 40-year span, February was the peak month in 17 seasons, but some years peaked in December, January, or even March.)

This winter spike is driven by a confluence of seasonal dynamics: colder temperatures and low humidity increase virus stability and transmission, while people crowding indoors (especially during holiday travel and gatherings) accelerates person-to-person spread.

Laboratory studies support these observations – influenza spreads most efficiently under cold, dry conditions. In one classic experiment, aerosol transmission of flu was completely blocked at high relative humidity (80%) but was highly efficient at low humidity (20–35%), and transmission became even more robust at chilly 5 °C ambient temperature. In essence, winter creates a perfect storm of environmental factors and human behaviors that give the flu virus an advantage.

Seasonality isn't just a local phenomenon.

Influenza outbreaks hit during the cold half of the year in each hemisphere – for example, countries in the Southern Hemisphere face their flu season from about April through September (their winter). Global public health experts often watch those earlier Southern Hemisphere outbreaks to anticipate what strains and severity might be coming up north.

Even so, flu season timing and severity can vary unpredictably.

Some seasons start unusually early or late. (The 2022–2023 U.S. season, for instance, saw an early surge with flu activity rising in October and peaking by early December.)

The health impact also fluctuates year to year. A mild season might hospitalize tens of thousands, while a bad season can infect and kill many more.

For perspective, CDC estimates that the 2022–2023 flu season caused about 31 million illnesses, 360,000 hospitalizations, and 21,000 deaths in the U.S. alone – a stark reminder of how hard flu season can hit. And in recent years, influenza hasn't been acting alone: the term "tripledemic" was coined as surges of RSV and COVID-19 have coincided with flu season, compounding the burden on hospitals and labs.

In short, when respiratory virus season arrives, it can become a multi-front battle. This reality underscores why laboratories, as much as clinics, must brace for the impact.

The Strain on Laboratories During Flu Season

Seasonal flu is a biological challenge, but for laboratories it's also very much an operational challenge. Diagnostic labs serve as frontline responders in flu season, responsible for quickly detecting and differentiating influenza infections – and now other respiratory viruses – from the torrent of patient samples that arrive during winter months.

When flu cases spike in the community, testing volumes surge correspondingly. Clinical laboratories may find themselves "processing" significantly more samples than usual, not just for influenza but also for look-alike illnesses such as COVID-19 and RSV.

For example, a medium-sized hospital lab that normally runs a few dozen respiratory tests per day could suddenly be running several hundred per day at the height of flu season. This volume spike puts pressure on everything: supplies, personnel, and turnaround times.

Supply management quickly becomes a critical concern. High demand for influenza test kits, reagents, swabs, personal protective equipment, and other consumables can lead to shortages or back-orders if a lab hasn't stocked up in advance.

Labs also must maintain quality control materials and reagents for influenza testing – all of which need to be on hand in larger quantities during peak season. The COVID-19 pandemic revealed how fragile supply chains can be when demand skyrockets, and flu season often presents a mini-version of that challenge for labs every winter.

Another challenge is differentiation and speed. Flu symptoms overlap with many other viruses, so labs increasingly rely on multiplex respiratory pathogen panels (RPPs) and specific influenza assays to get answers fast.

These multiplex PCR panels can detect influenza A, influenza B, SARS-CoV-2, RSV, and other viruses in one go, which is invaluable when a patient could be suffering from any of several circulating bugs. Using such panels (or a combination of targeted rapid PCR tests) allows labs to identify which pathogen is causing a patient's illness within hours, enabling clinicians to provide the right treatment (for example, antiviral medication for flu versus isolation for COVID-19) without delay.

The ability to distinguish influenza from other infections quickly is not only vital for patient care, but also for public health surveillance – labs report flu detections to public health agencies to help track the outbreak in real time.

In peak season, turnaround time (TAT) becomes critical; doctors and infection control teams are anxiously awaiting results. Thus, labs must juggle high throughput and high accuracy under intense time pressure.

All of this happens while the lab's workforce is stretched thin. Staffing can become a limiting factor: analysts and technologists face longer shifts or extra runs to keep up with testing demand. If a severe flu wave hits, lab staff may also be out sick themselves, further straining capacity.

It's easy to see how, without preparation, a lab could become overwhelmed – instruments running non-stop, phone lines jammed with inquiries, and exhausted scientists racing to avoid backlogs. The difference between chaos and controlled urgency comes down to one thing: preparedness.

Proactive Strategies for Lab Preparedness

Flu season may be inevitable, but high impact on lab operations doesn't have to be. The key is proactive planning and surge-ready strategies. Laboratory leaders – especially those in diagnostic and research labs – can take concrete steps before the seasonal spike to ensure their teams and facilities are ready to weather the storm. Here are several proven preparedness measures for labs heading into flu season:

• Audit Inventory and Consumables: Perform a thorough inventory of critical supplies (e.g. viral transport swabs, PCR reagents, test cartridges, extraction kits, and positive control material) well before flu cases peak. Verify that stock levels are sufficient and that items aren't nearing expiration. This includes checking point-of-care test (POCT) kit inventory if your facility uses rapid tests. In one illustrative case, a multi-site lab network avoided a major disruption during flu season by pre-verifying and stocking extra test kit lots in advance – when a manufacturer issued an unexpected recall mid-season, the lab seamlessly switched to its validated backup lots with no downtime. Such an inventory audit should also encompass quality controls and calibration materials needed for influenza assays. Essentially, know what you have on hand, and what you might run out of.
• Validate Backup Testing Kits/Platforms: Redundancy is a lifeline in flu season. Labs should identify and prepare alternate testing methods in case the primary assay or instrument becomes unavailable. For example, if your lab's main flu test is a high-throughput PCR platform, have a backup rapid PCR or antigen kit validated as a contingency. This means completing any necessary correlation studies or verification before flu season, so that switching over can be done immediately if needed. The same goes for having multiple suppliers or kit brands approved – don't rely on a single source. If one vendor's product is delayed or recalled, a validated backup ensures you can continue testing uninterrupted. Investing time in cross-validation now can save precious days of downtime later.
• Implement Surge Staffing and Schedules: Human resource planning is crucial for a smooth response. Anticipate the need for extra hands and longer hours when flu test volumes climb. Labs can arrange surge schedules such as adding evening/weekend shifts or on-call rotations during the winter months. It's wise to cross-train staff on multiple platforms (molecular PCR, rapid antigen, sample accessioning, etc.) so that no single person becomes a bottleneck. For example, training some additional technologists or even non-technical staff (e.g. research assistants or phlebotomists) to run rapid flu or COVID tests can provide emergency coverage if key personnel are out sick. Ensure that backup personnel are not just names on paper – they should be truly competent and ready to step in. Consider staggering shift start times to extend overall lab hours without exhausting the core team. The goal is to maintain turnaround times and quality even at double or triple the usual sample load, and to do it without burning out your team.
• Establish Reorder Thresholds and Supply Chain Safeguards: During flu season, don't wait until you're nearly out of supplies to reorder. Instead, set higher minimum-par levels and reorder triggers based on usage rates and vendor lead times. For instance, if a certain PCR kit normally ships in 2 weeks, make sure to reorder when you still have more than 2 weeks' worth of tests on hand (you might order at 4 weeks' supply remaining, to be safe). Monitoring consumption rates from previous seasons can help predict when demand will surge. It's also prudent to diversify suppliers for critical items. Establish relationships and standing agreements with multiple vendors for things like reagents and PPE. That way, if one supplier faces a shortage, you have alternatives ready. In sum, build slack into your supply chain: extra stock, secondary suppliers, and quick reordering practices. This proactive approach can prevent the nightmare of halted testing due to an empty reagent shelf.

By taking these steps ahead of time, labs can transform flu season from a scramble into a controlled surge. Preparedness measures act as a pressure release valve – they safeguard workflow continuity when testing demand spikes, and they give lab staff the tools and confidence to handle the influx without crisis.

Building Resilience for Peak Season

Ultimately, a busy flu season isn't just a test of biology – it's a test of a lab's resilience and planning. With influenza and other respiratory viruses poised to strike each winter, successful laboratories approach the season not with trepidation, but with a well-drilled game plan. From supply closets to staff schedules, every aspect of operations is fortified to absorb the stress of a surge.

As we've discussed, foresight is everything: stocking and redundancy prevent supply crunches, training and smart scheduling avert personnel crises, and rapid diagnostics ensure patients get answers when it matters most.

By investing in these proactive strategies, senior lab leaders can ensure their facilities remain agile and dependable even at the height of flu season's chaos. The payoff is immense – workflows stay up and running, downtime is minimized, and critical results keep flowing to clinicians and public health officials when demand is at its peak. In the face of influenza's yearly assault, laboratories that plan and prepare can do more than cope; they can excel, turning a yearly challenge into an opportunity to demonstrate excellence in diagnostics.

The flu season will always hit hard, but with preparation, our labs can hit back harder – and save countless lives in the process.

---

Sources:

1. CDC — Influenza Season in the U.S.: peak activity by month
2. CDC — 2022–2023 Seasonal Influenza Burden (31 million illnesses, etc.)
3. Families Fighting Flu — 2022-2023 early flu season and "tripledemic" summary
4. CDC Center for Forecasting (Respiratory Season Outlook) — flu typically peaks Dec–Feb (timing varies)
5. LabLynx LIMS Guide — Seasonal surge factors and lab challenges (testing volume, TAT, supply)
6. Sparks & Sage Lab Consulting — Respiratory season multi-pathogen challenge and preparedness tips
7. PLOS Pathogens (Lowen et al.) — Experimental data: low humidity & 5 °C boost flu transmission
8. CIDRAP News — Southern Hemisphere flu season timing (Apr–Sept)